Clinical Trials Logo

Female Contraception clinical trials

View clinical trials related to Female Contraception.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06394999 Not yet recruiting - Clinical trials for Female Contraception

Efficacy, Safety, and Acceptability of Mifepristone 50 mg Once-weekly as a Contraceptive

WOMEN
Start date: September 2024
Phase: Phase 3
Study type: Interventional

Participants in the study will use mifepristone 50 mg once-a-week for one year as a contraceptive. With this, we want to confirm that the chances of getting pregnant while using this contraceptive are very small. We also want to demonstrate that the use of mifepristone is safe, and it does not lead to any severe health problems. We expect fewer side effects compared to other frequently used contraceptives with hormones. Mifepristone does not contain these hormones. It is important to know how people experience that use of one tablet a week.